| 000 | 01773 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513205218.0 | ||
| 264 | 0 | _c20000630 | |
| 008 | 200006s 0 0 eng d | ||
| 022 | _a0021-9258 | ||
| 024 | 7 |
_a10.1074/jbc.M909616199 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHeeneman, S | |
| 245 | 0 | 0 |
_aAngiotensin II induces transactivation of two different populations of the platelet-derived growth factor beta receptor. Key role for the p66 adaptor protein Shc. _h[electronic resource] |
| 260 |
_bThe Journal of biological chemistry _cMay 2000 |
||
| 300 |
_a15926-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAngiotensin II _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xpharmacology |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aPhosphotyrosine _xanalysis |
| 650 | 0 | 4 |
_aPlatelet-Derived Growth Factor _xpharmacology |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptor, Platelet-Derived Growth Factor beta _xmetabolism |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aTranscriptional Activation _xdrug effects |
| 650 | 0 | 4 |
_aTyrphostins _xpharmacology |
| 650 | 0 | 4 | _asrc Homology Domains |
| 700 | 1 | _aHaendeler, J | |
| 700 | 1 | _aSaito, Y | |
| 700 | 1 | _aIshida, M | |
| 700 | 1 | _aBerk, B C | |
| 773 | 0 |
_tThe Journal of biological chemistry _gvol. 275 _gno. 21 _gp. 15926-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.M909616199 _zAvailable from publisher's website |
| 999 |
_c10701539 _d10701539 |
||